Julie Lin

Julie Lin currently serves as Senior Vice President of Clinical Development and Clinical Pharmacology at Travere Therapeutics, overseeing drug development and executive leadership. Concurrently, Julie Lin is a Principal at QHIA Consulting, providing career advising to biotechnology leaders. Previously, at Sanofi, Julie Lin held key roles as Senior Global Project Head for Rare Disease and led various initiatives in rare bone, blood, and kidney diseases while chairing expert committees. Prior experience includes roles as Associate Epidemiologist and Associate Physician at Brigham and Women's Hospital, along with academic positions at Harvard Medical School. Julie Lin holds an A.B. in Biology from Harvard University.